NO965305D0 - Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler - Google Patents

Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler

Info

Publication number: NO965305D0
Authority: NO; Norway
Prior art keywords: hydrogen atom; preparation; tumor agents; methods; group
Prior art date: 1994-06-14

Application number

NO965305A

Other languages

English (en)

Other versions

NO307255B1 (no

NO965305L (no

Inventor

Kyoji Tomita

Katsumi Chiba

Shigeki Kashimoto

Koh-Ichiro Shibamori

Yasunori Tsuzuki

Original Assignee

Dainippon Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-14

Filing date

1996-12-11

Publication date

1996-12-11

1996-12-11 Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co

1996-12-11 Publication of NO965305D0 publication Critical patent/NO965305D0/no

1997-02-04 Publication of NO965305L publication Critical patent/NO965305L/no

2000-03-06 Publication of NO307255B1 publication Critical patent/NO307255B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO965305A 1994-06-14 1996-12-11 Nye forbindelser og antitumormidler NO307255B1 (no)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
JP15657894		1994-06-14
JP19792194		1994-07-28
JP30691494		1994-11-15
JP33995694		1994-12-28
JP8170595		1995-03-13
PCT/JP1995/001110 WO1995034559A1 (fr)	1994-06-14	1995-06-06	Nouveau compose, son procede de production et agent antitumoral

Publications (3)

Publication Number	Publication Date
NO965305D0 true NO965305D0 (no)	1996-12-11
NO965305L NO965305L (no)	1997-02-04
NO307255B1 NO307255B1 (no)	2000-03-06

Family

ID=27524935

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO965305A NO307255B1 (no)	1994-06-14	1996-12-11	Nye forbindelser og antitumormidler

Country Status (27)

Country	Link
US (1)	US5817669A (no)
EP (1)	EP0787726B1 (no)
JP (1)	JP3391796B2 (no)
KR (1)	KR100350921B1 (no)
CN (1)	CN1053668C (no)
AT (1)	ATE209645T1 (no)
AU (1)	AU679859B2 (no)
BR (1)	BR9508037A (no)
CA (1)	CA2192824C (no)
CZ (1)	CZ292631B6 (no)
DE (1)	DE69524251T2 (no)
DK (1)	DK0787726T3 (no)
ES (1)	ES2163512T3 (no)
FI (1)	FI112485B (no)
HK (1)	HK1000495A1 (no)
HU (1)	HU220072B (no)
MX (1)	MX9606331A (no)
NO (1)	NO307255B1 (no)
NZ (1)	NZ287139A (no)
PL (1)	PL181867B1 (no)
PT (1)	PT787726E (no)
RO (1)	RO117793B1 (no)
RU (1)	RU2151770C1 (no)
SI (1)	SI0787726T1 (no)
SK (1)	SK281341B6 (no)
TW (1)	TW319769B (no)
WO (1)	WO1995034559A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1578781A (zh)	2001-09-26	2005-02-09	拜尔药品公司	用作抗糖尿病药物的1,8－萘啶衍生物
US6802423B2 (en) *	2002-02-20	2004-10-12	Trans Global Foods, Inc.	Disposable food delivery apparatus
WO2004091627A2 (en) *	2003-04-07	2004-10-28	Cylene Pharmaceuticals, Inc.	Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
SG144936A1 (en) *	2003-09-10	2008-08-28	Kyorin Seiyaku Kk	7-(4-substituted-3-cyclopropylaminomethyl-1- pyrrolidinyl)quinolonecarboxylic acid derivative
DE10352979A1 (de) *	2003-11-13	2005-06-09	Merck Patent Gmbh	Pyridopyrimidinone
AU2013201203C1 (en) *	2004-03-15	2015-04-23	Sumitomo Dainippon Pharma Co., Ltd.	Sns-595 and methods of using the same
EP1729770B1 (en) *	2004-03-15	2009-12-16	Sunesis Pharmaceuticals, Inc.	Sns-595 and methods of using the same
US7563805B2 (en) *	2005-05-19	2009-07-21	Daiichi Pharmaceutical Co., Ltd.	Tri-, tetra-substituted-3-aminopyrrolidine derivative
CA2619663A1 (en) *	2005-08-19	2007-02-22	Cylene Pharmaceuticals, Inc.	Human ribosomal dna(rdna) and ribosomal rna (rrna) nucleic acids and uses thereof
CN104873502A (zh) *	2005-09-02	2015-09-02	逊尼希思制药公司	使用(+)-1,4-二氢-7-[(3s,4s)-3-甲氧基-4-(甲氨基)-1-吡咯烷基]-4-氧代-1-(2-噻唑基)-1,8-萘啶-3-羧酸治疗癌症的方法
JP5374153B2 (ja) *	2005-09-02	2013-12-25	サネシスファーマシューティカルズ，インコーポレイテッド	癌の治療のための（＋）−１，４−ジヒドロ−７−［（３ｓ，４ｓ）−３−メトキシ−４−（メチルアミノ）−１−ピロリジニル］−４−オキソ−１−（２−チアゾリル）−１，８−ナフチリジン−３−カルボン酸を使用する方法
US8580814B2 (en) *	2006-04-03	2013-11-12	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
AU2013219242C1 (en) *	2005-09-02	2016-09-22	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
EP1931339B1 (en) *	2005-09-02	2018-05-16	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
TW200800983A (en)	2005-09-14	2008-01-01	Janssen Pharmaceutica Nv	5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
US7642270B2 (en)	2005-09-14	2010-01-05	Janssen Pharmaceutica N.V.	5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
WO2007033232A1 (en) *	2005-09-14	2007-03-22	Janssen Pharmaceutica, N.V.	5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
EP2354138A1 (en) *	2006-06-12	2011-08-10	Sunesis Pharmaceuticals, Inc.	Compounds and compositions for treatment of cancer
US20100048609A1 (en) *	2006-08-01	2010-02-25	Jacobs Jeffrey W	Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
CA2659861A1 (en)	2006-08-02	2008-02-07	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
MX2010004350A (es) *	2007-10-22	2010-05-19	Sunesis Pharmaceuticals Inc	Metodos de uso del acido (+)-1,4-dihidro-7-[(3s,4s)]-3-metoxi-4-(m etilamino)-1-pirrolidinil-4-oxo-1-(2-tiazolil)-1, 8-naftiridina-3-carboxilico en terapias de combinacion.
EP2649997B1 (en) *	2007-12-10	2019-01-23	Sunesis Pharmaceuticals, Inc.	(+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in the treatment of myelodyspastic syndrome
RU2015106671A (ru) *	2008-12-31	2015-06-27	Санесис Фармасьютикалз, Инк.	Способ получения (+)-1,4-дигидро-7-[(3s,4s)-3-метокси-4-(метиламино)-1-пирролидинил]-4-оксо-1-(2-тиазолил)-1,8-нафтиридин-3-карбоновой кислоты
NZ594829A (en)	2009-02-27	2013-09-27	Sunesis Pharmaceuticals Inc	Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
UA110465C2 (en)	2009-09-04	2016-01-12	Sunesis Pharmaceutecals Inc	Stable sns-595 composition
US8470817B2 (en) *	2009-10-26	2013-06-25	Sunesis Pharmaceuticals, Inc.	Compounds and methods for treatment of cancer
MX369142B (es)	2011-05-13	2019-10-30	Array Biopharma Inc	Compuestos intermediarios de fórmula ii, útiles en la preparación de compuestos derivados de pirrolidinil como inhibidores de cinasa trka.
CN103497186B (zh) *	2013-09-24	2015-02-25	浙江司太立制药股份有限公司	含有烷氧亚氨基取代的萘啶酮羧酸衍生物及其制备方法
JP7518618B2 (ja) *	2017-03-24	2024-07-18	湧永製薬株式会社	新規ピリドンカルボン酸誘導体又はその塩

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4730000A (en) *	1984-04-09	1988-03-08	Abbott Laboratories	Quinoline antibacterial compounds
DE3577089D1 (de) *	1984-01-26	1990-05-17	Abbott Lab	Antibakterielle chinolinderivate.
NZ210847A (en) *	1984-01-26	1988-02-29	Abbott Lab	Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
JPS61152682A (ja) *	1984-12-27	1986-07-11	Dainippon Pharmaceut Co Ltd	ピリドンカルボン酸誘導体、そのエステルおよびその塩
JPS61251667A (ja) *	1985-04-30	1986-11-08	Otsuka Pharmaceut Co Ltd	ベンゾヘテロ環化合物
GR861530B (en) *	1985-06-13	1986-12-31	Schering Corp	Preparation process for polycyclic quinoline of naphthyridine and pyrazinopyridine
WO1986007357A2 (en) *	1985-06-14	1986-12-18	Upjohn Co	Cyclopentapyrazole and tetrahydroindazole compounds
JPS6233176A (ja) *	1985-08-05	1987-02-13	Toyama Chem Co Ltd	１，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JP2704428B2 (ja) *	1988-06-15	1998-01-26	富山化学工業株式会社	キノロンカルボン酸誘導体またはその塩
DE3906365A1 (de) *	1988-07-15	1990-01-18	Bayer Ag	7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JPH06233176A (ja) *	1993-01-29	1994-08-19	Sony Corp	ビデオカメラ

1995
- 1995-06-06 EP EP95920265A patent/EP0787726B1/en not_active Expired - Lifetime
- 1995-06-06 CN CN95194461A patent/CN1053668C/zh not_active Expired - Lifetime
- 1995-06-06 SK SK1574-96A patent/SK281341B6/sk not_active IP Right Cessation
- 1995-06-06 US US08/765,232 patent/US5817669A/en not_active Expired - Lifetime
- 1995-06-06 AU AU25767/95A patent/AU679859B2/en not_active Expired
- 1995-06-06 PT PT95920265T patent/PT787726E/pt unknown
- 1995-06-06 WO PCT/JP1995/001110 patent/WO1995034559A1/ja active IP Right Grant
- 1995-06-06 BR BR9508037A patent/BR9508037A/pt not_active IP Right Cessation
- 1995-06-06 RU RU97100718/04A patent/RU2151770C1/ru active
- 1995-06-06 DE DE69524251T patent/DE69524251T2/de not_active Expired - Lifetime
- 1995-06-06 KR KR1019960707029A patent/KR100350921B1/ko not_active IP Right Cessation
- 1995-06-06 MX MX9606331A patent/MX9606331A/es unknown
- 1995-06-06 CZ CZ19963643A patent/CZ292631B6/cs not_active IP Right Cessation
- 1995-06-06 ES ES95920265T patent/ES2163512T3/es not_active Expired - Lifetime
- 1995-06-06 CA CA002192824A patent/CA2192824C/en not_active Expired - Lifetime
- 1995-06-06 HU HU9603455A patent/HU220072B/hu unknown
- 1995-06-06 NZ NZ287139A patent/NZ287139A/en not_active IP Right Cessation
- 1995-06-06 AT AT95920265T patent/ATE209645T1/de active
- 1995-06-06 RO RO96-02349A patent/RO117793B1/ro unknown
- 1995-06-06 PL PL95317726A patent/PL181867B1/pl unknown
- 1995-06-06 DK DK95920265T patent/DK0787726T3/da active
- 1995-06-06 SI SI9530567T patent/SI0787726T1/xx unknown
- 1995-06-06 JP JP50192396A patent/JP3391796B2/ja not_active Expired - Lifetime
- 1995-06-13 TW TW084106000A patent/TW319769B/zh not_active IP Right Cessation
1996
- 1996-12-11 NO NO965305A patent/NO307255B1/no not_active IP Right Cessation
- 1996-12-13 FI FI965020A patent/FI112485B/fi not_active IP Right Cessation
1997
- 1997-10-17 HK HK97101948A patent/HK1000495A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0787726T3 (da)	2002-02-11
TW319769B (no)	1997-11-11
EP0787726B1 (en)	2001-11-28
AU679859B2 (en)	1997-07-10
RO117793B1 (ro)	2002-07-30
SK281341B6 (sk)	2001-02-12
RU2151770C1 (ru)	2000-06-27
CN1053668C (zh)	2000-06-21
EP0787726A4 (no)	1997-08-06
DE69524251T2 (de)	2002-07-11
SK157496A3 (en)	1997-08-06
AU2576795A (en)	1996-01-05
NZ287139A (en)	1997-07-27
ES2163512T3 (es)	2002-02-01
HUT75777A (en)	1997-05-28
CN1158614A (zh)	1997-09-03
KR100350921B1 (ko)	2002-11-18
FI965020A0 (fi)	1996-12-13
WO1995034559A1 (fr)	1995-12-21
SI0787726T1 (en)	2002-04-30
PL181867B1 (pl)	2001-09-28
FI112485B (fi)	2003-12-15
HU220072B (hu)	2001-10-28
HU9603455D0 (en)	1997-02-28
CA2192824C (en)	2006-11-07
CA2192824A1 (en)	1995-12-21
PT787726E (pt)	2002-04-29
PL317726A1 (en)	1997-04-28
MX9606331A (es)	1997-03-29
FI965020A (fi)	1996-12-16
EP0787726A1 (en)	1997-08-06
DE69524251D1 (de)	2002-01-10
JP3391796B2 (ja)	2003-03-31
BR9508037A (pt)	1997-09-16
US5817669A (en)	1998-10-06
CZ364396A3 (en)	1997-06-11
HK1000495A1 (en)	2002-07-19
NO307255B1 (no)	2000-03-06
CZ292631B6 (cs)	2003-11-12
NO965305L (no)	1997-02-04
ATE209645T1 (de)	2001-12-15

Publication	Publication Date	Title
NO965305D0 (no)	1996-12-11	Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler
NO992549D0 (no)	1999-05-27	Sukkerforbindelse, geleringsmiddel og fremgangsmÕte for fremstilling derav
NO955023L (no)	1995-12-12	Piperidinderivater og fremgangsmåte for fremstilling derav
DK436081A (da)	1982-04-04	Substituerede acyl-derivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyrer og farmaceutisk acceptable salte deraf fremgangsmaade til deres fremstilling og deres anvendelse
FI972460A0 (fi)	1997-06-10	Aniliinijohdannaiset joilla on typpimonoksidisyntaasiesto aktiivisuus
NO913725D0 (no)	1991-09-23	Benzen-, pyridin- og pyrimidin-derivater og fremgangsmaatefor deres fremstilling.
PT87578A (pt)	1989-05-31	Process for the preparation of new alkanesulfonanilide derivatives and of pharmaceutical composition comprising the same
NZ221699A (en)	1990-03-27	Pyridazinone derivatives; pharmaceutical compositions and intermediates
GR3033519T3 (en)	2000-09-29	Substituted pyridinesulfonamide compounds, herbicidal compositions containing them, and process for their production.
ATE100077T1 (de)	1994-01-15	2-hydroxy-3-phenoxypropylaminoverbindungen.
YU165791A (sh)	1994-05-10	Postupak za pripremanje derivata 8-hlorohinolona
DK0812838T3 (da)	2002-08-19	Pyridoncarboxylsyrederivater substitueret med bicyclisk aminogruppe, estere og salte deraf og bicyclisk amin som mellemprodukt
DE3667788D1 (de)	1990-02-01	Diphenyletherherbizide.
ATE122683T1 (de)	1995-06-15	Epoxybernsteinsäurederivate, verwendbar als spezifische hemmer von cathepsin b.
EP1112998A4 (en)	2002-09-11	AMINE DERIVATIVES
ATE139767T1 (de)	1996-07-15	Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte
MY104164A (en)	1994-02-28	Heterocyclic compounds.
NO941757L (no)	1994-05-10	1-fenylpyrrolidon-derivater med optisk aktivitet, mellomprodukter for fremstilling derav og fremgangsmåter for deres fremstilling

Legal Events

Date	Code	Title	Description
2015-06-15	MK1K	Patent expired